IL33 and neoplasm: Therefore, to test whether decreased TNF-α and increased IL-33 do indeed lead to increased numbers of CD103+ DCs in the tumor microenvironment, we stained the tumor sections for both CD11c and CD103 and observed a significant increase in both DC markers (Figure 9F and Supplemental Figure 7D).